Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Non-Current Assets: 2020-2024

Historic Other Non-Current Assets for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $383,000.

  • Biofrontera's Other Non-Current Assets rose 23.24% to $472,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $472,000, marking a year-over-year increase of 23.24%. This contributed to the annual value of $383,000 for FY2024, which is 20.54% down from last year.
  • Biofrontera's Other Non-Current Assets amounted to $383,000 in FY2024, which was down 20.54% from $482,000 recorded in FY2023.
  • Over the past 5 years, Biofrontera's Other Non-Current Assets peaked at $482,000 during FY2023, and registered a low of $268,000 during FY2021.
  • For the 3-year period, Biofrontera's Other Non-Current Assets averaged around $395,000, with its median value being $383,000 (2024).
  • In the last 5 years, Biofrontera's Other Non-Current Assets surged by 50.63% in 2023 and then decreased by 20.54% in 2024.
  • Yearly analysis of 5 years shows Biofrontera's Other Non-Current Assets stood at $323,000 in 2020, then dropped by 17.03% to $268,000 in 2021, then increased by 19.40% to $320,000 in 2022, then surged by 50.63% to $482,000 in 2023, then decreased by 20.54% to $383,000 in 2024.